Open AccessDarunavir/ritonavir 600/100 mg once daily: it’s time for larger non-inferiority randomized trials
Author(s) -
S Nicolè,
Massimiliano Lanzafame,
Giulia Cucchetto,
F Rigo,
E Lattuada,
Ercole Concia
Publication year - 2018
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dky086
Subject(s) - darunavir , medicine , randomized controlled trial , ritonavir , human immunodeficiency virus (hiv) , antiretroviral therapy , virology , viral load
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom